The ACMA Medical Affairs Leadership Summit returns on April 30, 2026, following a sold-out event in 2025 that left Medical Affairs & MSL Industry Leaders wanting more.
This one-day, in-person event exclusively brings together top executives and visionary Medical Affairs leaders across the Pharmaceutical and Life Sciences Industries.
20-minute power talks with 30 minutes of brainstorming & collaboration sessions for each topic.
20-minute power talks with 30 minutes of brainstorming & collaboration sessions for each topic.
Get real-world insights into challenges and innovations shaping our industry and strategies that truly make a measurable impact.
Build powerful peer relationships with executives from leading companies in an environment designed for connection and collaboration.
An event specifically curated and designed for maximum value with actionable outcomes.
"Absolutely the most relevant, high-impact Medical Affairs event I've attended all year."
"The speaker lineup was world-class. Every session delivered value."
"This wasn't just a conference, it was a leadership experience."
Come away with real-world insights and strategies that will make an impact in your partnerships.
This panel explores how medical affairs teams can navigate reputational and operational crisis. Experts will share real-world scenarios and best practices for preparing, responding, and recovering effectively while preserving credibility and compliance.
This hands-on session focuses on how medical affairs can communicate scientific value in a business-focused context. Attendees will explore practical ways to align with executive priorities and strengthen their voice at the leadership table.
With constant shifts in global and national policies, the regulatory environment feels more unpredictable than ever. This session will help medical affairs leaders make sense of the chaos, stay ahead of rapid changes, and develop strategies to remain compliant, agile, and aligned with business needs.
Engage with Clinical Investigator Thought Leaders, learn about challenges and changes impacting them, and what Clinical Investigators really want from Pharma partners.
Engage with a learning healthcare equity analyst from a leading financial firm that will break down how institutional investors and Wall Street evaluate pharmaceutical and biotech companies, not just on pipeline assets, but also on how effectively they activate medical affairs strategies.
Join us as we honor the outstanding achievements within medical affairs over the past year. These prestigious awards will recognize leaders and teams who have driven innovation, strategic excellence, and measurable impact.
This panel explores how medical affairs teams can navigate reputational and operational crisis. Experts will share real-world scenarios and best practices for preparing, responding, and recovering effectively while preserving credibility and compliance.
This hands-on session focuses on how medical affairs can communicate scientific value in a business-focused context. Attendees will explore practical ways to align with executive priorities and strengthen their voice at the leadership table.
With constant shifts in global and national policies, the regulatory environment feels more unpredictable than ever. This session will help medical affairs leaders make sense of the chaos, stay ahead of rapid changes, and develop strategies to remain compliant, agile, and aligned with business needs.
Engage with Clinical Investigator Thought Leaders, learn about challenges and changes impacting them, and what Clinical Investigators really want from Pharma partners.
Engage with a learning healthcare equity analyst from a leading financial firm that will break down how institutional investors and Wall Street evaluate pharmaceutical and biotech companies, not just on pipeline assets, but also on how effectively they activate medical affairs strategies.
Join us as we honor the outstanding achievements within medical affairs over the past year. These prestigious awards will recognize leaders and teams who have driven innovation, strategic excellence, and measurable impact.
A leader who has elevated the role of MSLs or driven impactful innovation in field medical strategy? ACMA is now accepting nominations for the 2026 Medical Affairs Awards, recognizing outstanding achievement, leadership, and impact in the field. Categories include:
The recipient of this award whose led remarkable initiatives, creativity, and leadership, contributing meaningfully to their organization
This award recognizes an entire organization or medical affairs team for their innovation in ensuring an excellent medical affairs team.
This award recognizes the exceptional performance and contributions of a medical science liaison (MSL) who has consistently gone above and beyond in their role.
Deadline: March 1, 2026. Self-nominations welcome.
Open to individuals across pharma, biotech, and medtech.